Nolte, F., Schumann, C., & Hofmann, W. (2013). Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload. Annals of hematology, 92(2), .
Chicago-Zitierstil (17. Ausg.)Nolte, Florian, Christiane Schumann, und Wolf-Karsten Hofmann. "Results from a 1-year, Open-label, Single Arm, Multi-center Trial Evaluating the Efficacy and Safety of Oral Deferasirox in Patients Diagnosed with Low and Int-1 Risk Myelodysplastic Syndrome (MDS) and Transfusion-dependent Iron Overload." Annals of Hematology 92, no. 2 (2013).
MLA-Zitierstil (9. Ausg.)Nolte, Florian, et al. "Results from a 1-year, Open-label, Single Arm, Multi-center Trial Evaluating the Efficacy and Safety of Oral Deferasirox in Patients Diagnosed with Low and Int-1 Risk Myelodysplastic Syndrome (MDS) and Transfusion-dependent Iron Overload." Annals of Hematology, vol. 92, no. 2, 2013.